Table 3.
Primary outcomes of included studies.
| Study | Postoperative patency rate | Short-term follow-up patency | Long-term follow-up patency | Short-term follow-up mortality | Long-term follow-up mortality |
|---|---|---|---|---|---|
| Morgan et al. (20) | 21 (100) | 21 (100) | 21 (100) | 0 | 1 (4.76) |
| Jafar et al. (21) | NR | NR | 26 (92.86) | 1 (3.7) | 1 (3.7) |
| Cantore et al. (22) | NR | NR | 37 (92.5) | 4 (10) | 4 (10) |
| Sanai et al. (13) | NR | NR | NR | 0 | 0 |
| Murakami et al. (23) | NR | NR | NR | 0 | NR |
| Xu et al. (24) | NR | NR | NR | 0 | 0 |
| Ramanathan et al. (25) | NR | NR | NR | 0 | 0 |
| Shi et al. (26) | NR | NR | NR | 0 | NR |
| Ishishita et al. (27) | 36 (97.3) | 37 (100) | 36 (97.3) | 0 | 0 |
| Kalani et al. (28) | NR | NR | 22 (91.67) | 0 | 0 |
| Rustemi et al. (29) | 22 (100) | NR | 18 (81.82) | 0 | 0 |
| White et al. (30) | NR | NR | NR | 0 | NR |
| Ban et al. (14) | NR | NR | NR | 0 | 0 |
| Abdulrauf et al. (31) | 30 (100) | 30 (100) | NR | 0 | NR |
| NR | 99 (90) | NR | 6 (5.45) | NR | |
| Matsukawa et al. (32) | 80 (100) | 80 (100) | 76 (95) | 0 | 0 |
| Nussbaum et al. (33) | NR | NR | 93 (97.89) | NR | 2 (2.11) |
| Ni et al. (34) | 31 (96.88) | NR | 27 (84.38) | 0 | 0 |
| Nurminen et al. (35) | NR | 25 (89.29) | 23 (82.14) | NR | NR |
| Natarajan et al. (36) | 23 (95.83) | 23 (95.83) | 22 (91.67) | 0 | 0 |
| Pescatori et al. (37) | NR | NR | 52 (94.55) | NR | 5 (9.09) |
| Dodier et al. (38) | NR | NR | 36 (92.31) | 0 | 0 |
Data presented as n (%). NR, non-reported.